Dana Darst, MSJ

Founder & Principal

​

Dana Darst brings over two decades of senior commercial leadership to the life sciences sector, spanning agile startups to the Fortune 500. He specializes in designing the clinical and commercial Go-To-Market infrastructure PE-backed portfolio companies need to thrive.

 

By building high-performance teams, he accelerates clinical trial timelines and revenue growth without compromising on cost containment or regulatory compliance.

 

Beyond operations, Dana is a leading advocate for the ethical deployment of responsible AI. He balances rapid healthcare innovation with a steadfast commitment to patient privacy. His approach ensures that emerging technologies serve both organizational goals and the broader public interest through high standards of integrity.

 

Overall, his unique blend of business development and legal knowledge is an asset to any healthcare & life sciences transformation team.

 

M.S. in Intellectual Property and Health Law, Seton Hall Law School;

B.S. in Environmental Sciences, Rutgers University.